Modeling a lethal prostate cancer variant with small-cell carcinoma features

Vassiliki Tzelepi1, Jiexin Zhang, Jing-Fang Lu

  • 1Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

Summary

New xenografts model small-cell prostate carcinoma (SCPC), revealing key gene changes like UBE2C upregulation and loss of AR/RB1/CCND1 expression. These models aid understanding of aggressive prostate cancer biology.

Related Concept Videos